Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Receivables (2020 - 2025)

Trulieve Cannabis has reported Receivables over the past 6 years, most recently at $10.5 million for Q4 2025.

  • Quarterly results put Receivables at $10.5 million for Q4 2025, up 26.65% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (up 26.65% YoY), and the annual figure for FY2025 was $10.5 million, up 26.65%.
  • Receivables for Q4 2025 was $10.5 million at Trulieve Cannabis, roughly flat from $10.5 million in the prior quarter.
  • Over the last five years, Receivables for TCNNF hit a ceiling of $29.5 million in Q2 2023 and a floor of $2.6 million in Q1 2021.
  • Median Receivables over the past 5 years was $10.1 million (2023), compared with a mean of $11.8 million.
  • Biggest five-year swings in Receivables: surged 2891.37% in 2021 and later crashed 76.89% in 2023.
  • Trulieve Cannabis' Receivables stood at $9.4 million in 2021, then skyrocketed by 209.79% to $29.0 million in 2022, then crashed by 76.89% to $6.7 million in 2023, then increased by 23.65% to $8.3 million in 2024, then rose by 26.65% to $10.5 million in 2025.
  • The last three reported values for Receivables were $10.5 million (Q4 2025), $10.5 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.